Dr. Daniel P Bax, MD Dermatology Medicare: Medicare Enrolled Practice Location: 6000 Brockton Drive, Lockport, NY 14094 Phone: 716-845-3400 Fax: 716-438-1430 |
News Archive
The U.S. Food and Drug Administration announced on Oct. 27 that it has approved, for the first time, an oncolytic (cancer-killing) viral therapy in the United States. The drug was approved for use against late-stage melanoma, a deadly skin cancer that can be difficult to treat.
NDS Surgical Imaging (NDSsi) today announced the industry's first stabilized LED backlight, available in all new 26" Radiance G2 High-Bright surgical displays. Backlight stabilization assures consistent brightness of images over the life of the display—specified at 25,000 hours—without any dimming or compromise in luminance output. The result is a new level of image clarity and consistency, with enhanced brightness, contrast and color.
The Global Antibiotic Research and Development Partnership and Evotec AG are today announcing the formation of a new strategic public-private partnership to tackle the growing threat of antimicrobial resistance.
Researchers at the University of Virginia examined the number and severity of subconcussive head impacts sustained by college football players over an entire season during practices and games. The researchers found that the number of head impacts varied depending on the intensity of the activity.
› Verified 8 days ago